| Bid Price | 355.10p | High Price | 377.11p |
|---|
| Ask Price | 385.00p | Low Price | 355.00p |
|---|
| Open Price | 369.90p | Spread | 7.77% |
|---|
| Prev Close | 362.45p | Volume | 9,953 |
|---|
Hemogenyx Pharmaceuticals PLC Historic Prices
| Date | Open | High | Low | Close | Volume |
|---|
| Jan 22, 2025 | 355.00 | 373.91 | 355.00 | 362.45 | 1,465 |
| Jan 21, 2025 | 351.34 | 374.90 | 350.10 | 363.50 | 3,836 |
| Jan 20, 2025 | 366.50 | 389.90 | 350.00 | 350.00 | 14,181 |
| Jan 17, 2025 | 370.10 | 399.90 | 363.97 | 376.95 | 16,726 |
| Jan 16, 2025 | 381.10 | 400.00 | 370.10 | 390.45 | 9,085 |
Hemogenyx Pharmaceuticals PLC Information
| Name | Hemogenyx Pharmaceuticals PLC | Index | |
|---|
| ISIN | GB00BQVXM815 | Epic | HEMO |
|---|
| Type | Equity | Currency | GBX |
|---|
| Record Status | Active | Trading Segment | SET3 |
|---|
| Industry | Biotechnology | Sector | Healthcare |
|---|
| EMS | 500 | Trading Status | Closed |
|---|
| Shares in Issue | 3.50 m | Prev Close | 362.45p |
|---|
| PE Ratio | | Market Cap | £12.97 m |
|---|
| Div Yield | 0 | Div per Share | £NaN |
|---|
| EPS | -£0.80 | Div Cover | NaN |
|---|
| PEG | n/a | EPS Growth (%) | 0.00 |
|---|
| ROCE | -0.463004 | DPS Growth (%) | 0 |
|---|
| Current Ratio | 4.378498 | Quick Ratio | 4.378498 |
|---|
Hemogenyx Pharmaceuticals PLC Director Deals
| Declared | Type | Director | Pos. | Volume / Price | Value |
|---|
| 30/01/20 | PLAC | Peter Redmond | NED | 555,556 @ £0.02 | £10,000.00 |
| 03/07/19 | TIN | Vladislav Sandler | CEO | 1,066,667 @ £0.00 | £0.00 |
| 12/02/18 | BUY | Adrian Thorpe Beeston | RES | 200,000 @ £0.02 | £4,200.00 |
| 07/02/18 | BUY | Vladislav Sandler | CEO | 26,800 @ £0.02 | £635.00 |
| 11/10/17 | BUY | Adrian Thorpe Beeston | RES | 400,000 @ £0.03 | £11,840.00 |
| 10/10/17 | BUY | Peter Redmond | NED | 155,000 @ £0.03 | £4,859.00 |
| 10/10/17 | BUY | Adrian Thorpe Beeston | RES | 317,683 @ £0.03 | £9,848.00 |
Hemogenyx Pharmaceuticals PLC News
